Literature DB >> 10938225

Fictive locomotion and scratching inhibit dorsal horn neurons receiving thin fiber afferent input.

A M Degtyarenko1, M P Kaufman.   

Abstract

In decerebrate paralyzed cats, we examined the effects of two central motor commands (fictive locomotion and scratching) on the discharge of dorsal horn neurons receiving input from group III and IV tibial nerve afferents. We recorded the impulse activity of 74 dorsal horn neurons, each of which received group III input from the tibial nerve. Electrical stimulation of the mesencephalic locomotor region (MLR), which evoked fictive static contraction or fictive locomotion, inhibited the discharge of 44 of the 64 dorsal horn neurons tested. The mean depth from the dorsal surface of the spinal cord of the 44 neurons whose discharge was inhibited by MLR stimulation was 1.77 +/- 0.04 mm. Fictive scratching, evoked by topical application of bicuculline to the cervical spinal cord and irritation of the ear, inhibited the discharge of 22 of the 29 dorsal horn neurons tested. Fourteen of the twenty-two neurons whose discharge was inhibited by fictive scratching were found to be inhibited by MLR stimulation as well. The mean depth from the dorsal surface of the cord of the 22 neurons whose discharge was inhibited by fictive scratching was 1.77 +/- 0.06 mm. Stimulation of the MLR or the elicitation of fictive scratching had no effect on the activity of 22 dorsal horn neurons receiving input from group III and IV tibial nerve afferents. The mean depth from the dorsal surface of the cord was 1.17 +/- 0.07 mm, a value that was significantly (P < 0.05) less than that for the neurons whose discharge was inhibited by either MLR stimulation or fictive scratching. We conclude that centrally evoked motor commands can inhibit the discharge of dorsal horn neurons receiving thin fiber input from the periphery.

Entities:  

Mesh:

Year:  2000        PMID: 10938225     DOI: 10.1152/ajpregu.2000.279.2.R394

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  7 in total

1.  Inhibition of midbrain-evoked tonic and rhythmic motor activity by cutaneous stimulation in decerebrate cats.

Authors:  C A Beyaert; P Haouzi; F Marchal
Journal:  Exp Brain Res       Date:  2003-01-31       Impact factor: 1.972

2.  Volatile anesthetic effects on midbrain-elicited locomotion suggest that the locomotor network in the ventral spinal cord is the primary site for immobility.

Authors:  Steven L Jinks; Milo Bravo; Shawn G Hayes
Journal:  Anesthesiology       Date:  2008-06       Impact factor: 7.892

3.  Exercise pressor reflex function is altered in spontaneously hypertensive rats.

Authors:  Scott A Smith; Maurice A Williams; Anna K Leal; Jere H Mitchell; Mary G Garry
Journal:  J Physiol       Date:  2006-10-05       Impact factor: 5.182

4.  Exercise Pressor Reflex Contributes to the Cardiovascular Abnormalities Characterizing: Hypertensive Humans During Exercise.

Authors:  Simranjit K Sidhu; Joshua C Weavil; Matthew J Rossman; Jacob E Jessop; Amber D Bledsoe; Michael J Buys; Mark S Supiano; Russell S Richardson; Markus Amann
Journal:  Hypertension       Date:  2019-10-14       Impact factor: 10.190

5.  Evidence for functional alterations in the skeletal muscle mechanoreflex and metaboreflex in hypertensive rats.

Authors:  Anna K Leal; Maurice A Williams; Mary G Garry; Jere H Mitchell; Scott A Smith
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-18       Impact factor: 4.733

6.  Central command dysfunction in rats with heart failure is mediated by brain oxidative stress and normalized by exercise training.

Authors:  Satoshi Koba; Ichiro Hisatome; Tatsuo Watanabe
Journal:  J Physiol       Date:  2014-06-27       Impact factor: 5.182

Review 7.  On the Influence of Group III/IV Muscle Afferent Feedback on Endurance Exercise Performance.

Authors:  Markus Amann; Hsuan-Yu Wan; Taylor S Thurston; Vincent P Georgescu; Joshua C Weavil
Journal:  Exerc Sport Sci Rev       Date:  2020-10       Impact factor: 6.642

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.